Format

Send to

Choose Destination

See 1 citation found by title matching your search:

J Law Med Ethics. 2019 Sep;47(3):465-467. doi: 10.1177/1073110519876182.

Lung Cancer Survival Gains: Contributions of Academia and Industry.

Author information

1
Bishal Gyawali, M.D., Ph.D., is with the Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, the Anticancer Fund, Belgium, and the Department of Oncology and Division of Cancer Care and Epidemiology, Queen's University, Kingston, Canada. Gauthier Bouche, M.D., M.P.H., is with the Anticancer Fund, Belgium Pan Pantziarka, Ph.D.,is with the Anticancer Fund, Belgium. Aaron S. Kesselheim, M.D., J.D., M.P.H., is with the Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Ameet Sarpatwari, Ph.D., J.D., is with the Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
PMID:
31560624
DOI:
10.1177/1073110519876182

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center